yclopentolate en es it fr

yclopentolate Brand names, yclopentolate Analogs

yclopentolate Brand Names Mixture

  • No information avaliable

yclopentolate Chemical_Formula


yclopentolate RX_link

No information avaliable

yclopentolate fda sheet

yclopentolate msds (material safety sheet)

yclopentolate MSDS

yclopentolate Synthesis Reference

No information avaliable

yclopentolate Molecular Weight

291.385 g/mol

yclopentolate Melting Point

139 oC (hydrochloride salt)

yclopentolate H2O Solubility

No information avaliable

yclopentolate State


yclopentolate LogP


yclopentolate Dosage Forms

Ophthalmic solution (eye drops)

yclopentolate Indication

Used mainly to produce mydriasis and cycloplegia for diagnostic purposes.

yclopentolate Pharmacology

Cyclopentolate is an anti-muscarinic in the same class as atropine and scopolamine. Cyclopentolate blocks the receptors in the muscles of the eye (muscarinic receptors). These receptors are involved controlling the pupil size and the shape of the lens. Cyclopentolate thus induces relaxation of the sphincter of the iris and the ciliary muscles. When applied topically to the eyes, it causes a rapid, intense cycloplegic and mydriatic effect that is maximal in 15 to 60 minutes; recovery usually occurs within 24 hours. The cycloplegic and mydriatic effects are slower in onset and longer in duration in patients who have dark pigmented irises.

yclopentolate Absorption

Absorbed following ophthalmic administration.

yclopentolate side effects and Toxicity

Oral LD50 in the rat is 4000 mg/kg and 960 mg/kg in the mouse. Symptoms of overdose include tachycardia, dizziness, dry mouth, behavioral disturbances, uncoordination and drowsiness.

yclopentolate Patient Information

No information avaliable

yclopentolate Organisms Affected

Humans and other mammals